A detailed analysis of treatment delay from the onset of symptoms in early rheumatoid arthritis patients

References

• van der Heijde DM. Joint erosions and patients with early rheumatoid arthritis. Br J Rheumatol 1995;34(Suppl 2):74–8.
   PubMedGoogle Scholar
• Fuchs HA, Kaye JJ, Callahan LF, Nance EP, Pincus T. Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease. J Rheumatol 1989;16:585–91.
   PubMed Web of Science ®Google Scholar
• Buckland-Wright JC, Clarke GS, Chikanza IC, Grahame R. Quantitative microfocal radiography detects changes in erosion area in patients with early rheumatoid arthritis treated with myocrisine. J Rheumatol 1993;20:243–7.
   PubMed Web of Science ®Google Scholar
• Egsmose C, Lund B, Borg G, Pettersson H, Berg E, Brodin U, . Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study. J Rheumatol 1995;22:2208–13.
   PubMed Web of Science ®Google Scholar
• O’Dell JR, Paulsen G, Haire CE, Blakely K, Palmer W, Wees S, . Treatment of early seropositive rheumatoid arthritis with minocycline: four-year followup of a double-blind, placebo-controlled trial. Arthritis Rheum 1999;42:1691–5.
   PubMed Web of Science ®Google Scholar
• Tsakonas E, Fitzgerald AA, Fitzcharles MA, Cividino A, Thorne JC, M’Seffar A, . Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study. J Rheumatol 2000;27:623–9.
   PubMed Web of Science ®Google Scholar
• Anderson JJ, Wells G, Verhoeven AC, Felson DT. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum 2000;43:22–9.
   PubMed Web of Science ®Google Scholar
• Lard LR, Visser H, Speyer I, vander Horst-Bruinsma IE, Zwinderman AH, Breedveld FC, . Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 2001;111:446–51.
   PubMed Web of Science ®Google Scholar
• Mottonen T, Hannonen P, Korpela M, Nissila M, Kautiainen H, Ilonen J, . Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum 2002;46:894–8.
   PubMed Web of Science ®Google Scholar
• Nell VP, Machold KP, Eberl G, Stamm TA, Uffmann M, Smolen JS. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford) 2004;43:906–14.
   PubMed Web of Science ®Google Scholar
• Kyburz D, Gabay C, Michel BA, Finckh A. The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study. Rheumatology (Oxford) 2011;50:1106–10.
   PubMed Web of Science ®Google Scholar
• Finckh A, Liang MH, van Herckenrode CM, de Pablo P. Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: a meta-analysis. Arthritis Rheum 2006;55:864–72.
   PubMed Web of Science ®Google Scholar
• van der Linden MP, le Cessie S, Raza K, van der Woude D, Knevel R, Huizinga TW, . Long-term impact of delay in assessment of patients with early arthritis. Arthritis Rheum 2010;62:3537–46.
   PubMed Web of Science ®Google Scholar
• Bosello S, Fedele AL, Peluso G, Gremese E, Tolusso B, Ferraccioli G. Very early rheumatoid arthritis is the major predictor of major outcomes: clinical ACR remission and radiographic non-progression. Ann Rheum Dis 2011;70:1292–5.
   PubMed Web of Science ®Google Scholar
• Bykerk VP, Keystone EC. What are the goals and principles of management in the early treatment of rheumatoid arthritis? Best Pract Res Clin Rheumatol 2005;19:147–61.
   PubMed Web of Science ®Google Scholar
• Raza K, Buckley CE, Salmon M, Buckley CD. Treating very early rheumatoid arthritis. Best Pract Res Clin Rheumatol 2006;20:849–63.
   PubMed Web of Science ®Google Scholar
• Raza K. The Michael Mason prize: early rheumatoid arthritis – the window narrows. Rheumatology (Oxford) 2010;49:406–10.
   PubMedGoogle Scholar
• Smolen JS, Landewe R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, . EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010;69:964–75.
   PubMed Web of Science ®Google Scholar
• Deighton C, O’Mahony R, Tosh J, Turner C, Rudolf M. Management of rheumatoid arthritis: summary of NICE guidance. Br Med J 2009;338:b702.
   PubMed Web of Science ®Google Scholar
• Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, . 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012;64:625–39.
   PubMed Web of Science ®Google Scholar
• Irvine S, Munro R, Porter D. Early referral, diagnosis, and treatment of rheumatoid arthritis: evidence for changing medical practice. Ann Rheum Dis 1999;58:510–13.
   PubMedGoogle Scholar
• Gray M, Nuki J. Audit of delay between symptom onset and commencement of disease modifying anti-rheumatic drugs (DMARDs) in patients with newly diagnosed rheumatoid arthritis referred to a hospital rheumatology unit. Rheumatology (Oxford) 2001;40(Suppl 1):60.
   Google Scholar
• Jeyaratnam R, Kerr LD, Spiera H, Crane RP, Pugh MT. A comparative analysis of the time taken from onset of symptoms of rheumatoid arthritis to initiation of disease modifying antirheumatic drugs at Mount Sinai Hospital, USA and the Birmingham Heartlands Hospital, UK. Rheumatology (Oxford) 2001;40(Suppl 1):29.
   Google Scholar
• Potter T, Mulherin D, Pugh M. Early intervention with disease-modifying therapy for rheumatoid arthritis: where do the delays occur? Rheumatology (Oxford) 2002;41:953–5; author reply 5.
   PubMed Web of Science ®Google Scholar
• Raza K, Stack R, Kumar K, Filer A, Detert J, Bastian H, . Delays in assessment of patients with rheumatoid arthritis: variations across Europe. Ann Rheum Dis 2011;70:1822–5.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Polanco E, Al Snih S, Kuo YF, Millan A, Rodriguez MA. Lag time between onset of symptoms and diagnosis in Venezuelan patients with rheumatoid arthritis. Rheumatol Int 2011;31:657–65.
   Google Scholar
• Nanji JA, Choi M, Ferrari R, Lyddell C, Russell AS. Time to consultation and disease-modifying antirheumatic drug treatment of patients with rheumatoid arthritis – Northern Alberta perspective. J Rheumatol 2012;39:707–11.
   Google Scholar
• Kumar K, Daley E, Carruthers DM, Situnayake D, Gordon C, Grindulis K, . Delay in presentation to primary care physicians is the main reason why patients with rheumatoid arthritis are seen late by rheumatologists. Rheumatology (Oxford) 2007;46:1438–40.
   PubMed Web of Science ®Google Scholar
• Feldman DE, Bernatsky S, Haggerty J, Leffondre K, Tousignant P, Roy Y, . Delay in consultation with specialists for persons with suspected new-onset rheumatoid arthritis: a population-based study. Arthritis Rheum 2007;57:1419–25.
   PubMed Web of Science ®Google Scholar
• Sheppard J, Kumar K, Buckley CD, Shaw KL, Raza K. ‘I just thought it was normal aches and pains’: a qualitative study of decision-making processes in patients with early rheumatoid arthritis. Rheumatology (Oxford) 2008;47:1577–82.
   PubMed Web of Science ®Google Scholar
• Kumar K, Daley E, Khattak F, Buckley CD, Raza K. The influence of ethnicity on the extent of, and reasons underlying, delay in general practitioner consultation in patients with RA. Rheumatology (Oxford) 2010;49:1005–12.
   PubMed Web of Science ®Google Scholar
• Stack RJ, Shaw K, Mallen C, Herron-Marx S, Horne R, Raza K. Delays in help seeking at the onset of the symptoms of rheumatoid arthritis: a systematic synthesis of qualitative literature. Ann Rheum Dis 2012;71:493–7.
   PubMed Web of Science ®Google Scholar
• Felson DT, Meenan RF, Dayno SJ, Gertman P. Referral of musculoskeletal disease patients by family and general practitioners. Arthritis Rheum 1985;28:1156–62.
   Google Scholar
• Glazier RH, Dalby DM, Badley EM, Hawker GA, Bell MJ, Buchbinder R, . Management of the early and late presentations of rheumatoid arthritis: a survey of Ontario primary care physicians. Can Med Assoc J 1996;155:679–87.
   PubMed Web of Science ®Google Scholar
• Sinclair D, Hull RG. Why do general practitioners request rheumatoid factor? A study of symptoms, requesting patterns and patient outcome. Ann Clin Biochem 2003;40:131–7.
   Google Scholar
• Suter LG, Fraenkel L, Holmboe ES. What factors account for referral delays for patients with suspected rheumatoid arthritis? Arthritis Rheum 2006;55:300–5.
   PubMed Web of Science ®Google Scholar
• Lard LR, Huizinga TW, Hazes JM, Vliet Vlieland TP. Delayed referral of female patients with rheumatoid arthritis. J Rheumatol 2001;28:2190–2.
   PubMedGoogle Scholar
• Palm O, Purinszky E. Women with early rheumatoid arthritis are referred later than men. Ann Rheum Dis 2005;64:1227–8.
   Google Scholar
• Tavares R, Pope JE, Tremblay JL, Thorne C, Bykerk VP, Lazovskis J, . Time to disease-modifying antirheumatic drug treatment in rheumatoid arthritis and its predictors: a national, multicenter, retrospective cohort. J Rheumatol 2012;39:2088–97.
   Google Scholar
• Jamal S, Alibhai SM, Badley EM, Bombardier C. Time to treatment for new patients with rheumatoid arthritis in a major metropolitan city. J Rheumatol 2011;38:1282–8.
   PubMed Web of Science ®Google Scholar
• Hernandez-Garcia C, Vargas E, Abasolo L, Lajas C, Bellajdell B, Morado IC, . Lag time between onset of symptoms and access to rheumatology care and DMARD therapy in a cohort of patients with rheumatoid arthritis. J Rheumatol 2000;27:2323–8.
   PubMedGoogle Scholar
• Chan KW, Felson DT, Yood RA, Walker AM. The lag time between onset of symptoms and diagnosis of rheumatoid arthritis. Arthritis Rheum 1994;37:814–20.
   PubMed Web of Science ®Google Scholar
• Fitzgerald A, de Coster C, McMillan S, Naden R, Armstrong F, Barber A, . Relative urgency for referral from primary care to rheumatologists: the Priority Referral Score. Arthritis Care Res (Hoboken) 2011;63:231–9.
   Web of Science ®Google Scholar
• van Nies JA, Brouwer E, van Gaalen FA, Allaart CF, Huizinga TW, Posthumus MD, . Improved early identification of arthritis: evaluating the efficacy of Early Arthritis Recognition Clinics. Ann Rheum Dis 2012;0:1–7.
   Google Scholar